‘Genetic scissors’ — India using same tech to find sickle cell cure as gene therapy approved by US FDA
New Delhi: The US Food and Drug Administration (USFDA) last week approved two breakthrough gene therapies — Casgevy by Vertex Pharmaceuticals and CRISPR Therapeutics, and Lyfgenia by Bluebird Bio — for sickle …
